Pharma giant taps AI to help diabetics sleep better • PhilSTAR Life

Applications of AI

Swiss pharmaceutical giant Roche artificial intelligence To predict nocturnal hypoglycemia and help patients with hypoglycemia Diabetes I can sleep without worrying.

Diabetes is a chronic metabolic disease characterised by elevated blood glucose levels, treated with insulin injections, and patients suffer from low blood glucose levels at night (hypoglycemia), which can disrupt sleep and require medical intervention.

Roche said its latest continuous glucose monitor is a wearable sensor that measures blood glucose levels every five minutes and works with an AI app.

“An integrated AI-powered predictive algorithm indicates your risk of hypoglycemia within the next 30 minutes, continuously predicts how your blood glucose levels will change over the next two hours, and estimates your risk of hypoglycemia overnight,” the company said.

The technology allows for “proactive intervention before blood glucose levels require immediate attention” and is “designed to reduce concerns and lower the risk of nocturnal hypoglycemia,” Roche added.

The company said it determined that its predictive AI algorithms exceeded high performance requirements in terms of accuracy and that the system met European health and safety standards.

Generative AI applications are Chat GPT Artificial intelligence has been attracting the most attention, but it is being increasingly deployed in a variety of areas, including assisting medical professionals, with applications such as language translation and image recognition.

According to the World Health Organization (WHO), more than 422 million people worldwide had diabetes in 2014, and rising obesity is contributing to an increase in the number of people with type 2 diabetes, which develops when the body becomes resistant to insulin or does not produce enough insulin. (AFP)

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *